These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7067956)

  • 1. Isolation of Clostridium difficile from patients with inactive Crohn's disease.
    Dorman SA; Liggoria E; Winn WC; Beeken WL
    Gastroenterology; 1982 Jun; 82(6):1348-51. PubMed ID: 7067956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile in Crohn's disease.
    Wright JM; Adams SP; Gribble MJ; Bowie WR
    Can J Surg; 1984 Sep; 27(5):435-7. PubMed ID: 6478320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases.
    Ricciardi R; Ogilvie JW; Roberts PL; Marcello PW; Concannon TW; Baxter NN
    Dis Colon Rectum; 2009 Jan; 52(1):40-5. PubMed ID: 19273954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
    Viscidi R; Willey S; Bartlett JG
    Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
    Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP
    Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Clostridium difficile and Campylobacter jejuni in relapses of inflammatory bowel disease.
    Gurian L; Klein K; Ward TT
    West J Med; 1983 Mar; 138(3):359-60. PubMed ID: 6858121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Clostridium difficile on inflammatory bowel disease.
    Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcerative colitis and Crohn's disease tissue cytotoxins.
    McLaren LC; Gitnick G
    Gastroenterology; 1982 Jun; 82(6):1381-8. PubMed ID: 7067958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversity.
    De Hertogh G; Aerssens J; de Hoogt R; Peeters P; Verhasselt P; Van Eyken P; Ectors N; Vermeire S; Rutgeerts P; Coulie B; Geboes K
    J Pathol; 2006 Aug; 209(4):532-9. PubMed ID: 16739113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease.
    Oliveira AG; Rocha GA; Rocha AM; Sanna Md; Moura SB; Dani R; Marinho FP; Moreira LS; Ferrari Mde L; Castro LP; Queiroz DM
    Helicobacter; 2006 Feb; 11(1):2-9. PubMed ID: 16423084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.
    Nguyen GC; Kaplan GG; Harris ML; Brant SR
    Am J Gastroenterol; 2008 Jun; 103(6):1443-50. PubMed ID: 18513271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clostridium difficile and its toxin in a series of cases of Crohn's disease and ulcerative colitis].
    Jonard PP; Fiasse R; Delmeee M; Vanheuverzwijn R; Dive C
    Acta Gastroenterol Belg; 1983; 46(5-6):220-9. PubMed ID: 6670447
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens.
    Blaser MJ; Miller RA; Lacher J; Singleton JW
    Gastroenterology; 1984 Oct; 87(4):888-94. PubMed ID: 6468876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C; Scribano ML
    Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and Isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia.
    Sechi LA; Scanu AM; Molicotti P; Cannas S; Mura M; Dettori G; Fadda G; Zanetti S
    Am J Gastroenterol; 2005 Jul; 100(7):1529-36. PubMed ID: 15984976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile and inflammatory bowel disease.
    Bartlett JG
    Gastroenterology; 1981 Apr; 80(4):863-5. PubMed ID: 7202955
    [No Abstract]   [Full Text] [Related]  

  • 17. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile in the normal adult faecal flora.
    Rotimi VO; Akindutire D
    Afr J Med Med Sci; 1986; 15(3-4):73-7. PubMed ID: 3031964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease.
    Meyers S; Mayer L; Bottone E; Desmond E; Janowitz HD
    Gastroenterology; 1981 Apr; 80(4):697-70. PubMed ID: 7202942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.